Treatment of Ankylosing Spondylitis / 대한류마티스학회지
The Journal of the Korean Rheumatism Association
;
: 1-9, 2006.
Article
Dans Coréen
| WPRIM
| ID: wpr-203402
ABSTRACT
The conventional approach to treatment of patients with ankylosing spondylitis (AS) have been rather limited in the last decades. Evidence is accumulating that tumor necrosis factor (TNF) blocker is highly effective in AS. This article reviews the most recent and the most pertinent advances in the treatment in AS. TNF blocker have been evaluated in a number of randomized controlled trials in AS and have been demonstrated to be effective in disease activity, function, and quality of life in these patients. TNF blocker is emerging as the best therapeutic option available for patients with AS.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Qualité de vie
/
Pelvispondylite rhumatismale
/
Facteur de nécrose tumorale alpha
Type d'étude:
Essai clinique contrôlé
Limites du sujet:
Humains
langue:
Coréen
Texte intégral:
The Journal of the Korean Rheumatism Association
Année:
2006
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS